Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

InflaRx (IFRX) Return on Sales (2023 - 2025)

InflaRx's Return on Sales history spans 3 years, with the latest figure at 4.85% for Q4 2025.

  • On a quarterly basis, Return on Sales rose 103257.0% to 4.85% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.34%, a 19.0% increase, with the full-year FY2025 number at 15.56%, down 1278.0% from a year prior.
  • Return on Sales hit 4.85% in Q4 2025 for InflaRx, down from 0.9% in the prior quarter.
  • Over the last five years, Return on Sales for IFRX hit a ceiling of 0.9% in Q3 2025 and a floor of 1037.43% in Q4 2024.
  • Historically, Return on Sales has averaged 125.64% across 3 years, with a median of 3.47% in 2025.
  • Biggest five-year swings in Return on Sales: tumbled -98368bps in 2024 and later soared 103257bps in 2025.
  • Tracing IFRX's Return on Sales over 3 years: stood at 53.74% in 2023, then crashed by -1830bps to 1037.43% in 2024, then surged by 100bps to 4.85% in 2025.
  • Business Quant data shows Return on Sales for IFRX at 4.85% in Q4 2025, 0.9% in Q3 2025, and 3.14% in Q2 2025.